Follow-up of patients with mycosis fungoides after interferon α2b treatment failure

INTRODUCTION: Treatment of T cell cutaneous lymphoma( CTCL) is a controversial subject and the effectiveness of treatment is still low. AIM: Report of single center experience of management CTCL after progression after first line treatment. MATERIAL AND METHODS: We present 41 patients with CTCL, 29...

Descripción completa

Detalles Bibliográficos
Autores principales: Chmielowska, Ewa, Studziński, Maciej, Giebel, Sebastian, Krause, Anna, Olejniczak, Monika, Grzanka, Aleksandra
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2015
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436229/
https://www.ncbi.nlm.nih.gov/pubmed/26015774
http://dx.doi.org/10.5114/pdia.2014.40941
_version_ 1782372035441197056
author Chmielowska, Ewa
Studziński, Maciej
Giebel, Sebastian
Krause, Anna
Olejniczak, Monika
Grzanka, Aleksandra
author_facet Chmielowska, Ewa
Studziński, Maciej
Giebel, Sebastian
Krause, Anna
Olejniczak, Monika
Grzanka, Aleksandra
author_sort Chmielowska, Ewa
collection PubMed
description INTRODUCTION: Treatment of T cell cutaneous lymphoma( CTCL) is a controversial subject and the effectiveness of treatment is still low. AIM: Report of single center experience of management CTCL after progression after first line treatment. MATERIAL AND METHODS: We present 41 patients with CTCL, 29 received interferon α2b in first line, and 12 of them received second line therapy. RESULTS: Overall response rate for second line therapy was 60%. CONCLUSIONS: Results of the follow-up of patients with mycosis fungoides after interferon α2b treatment failure with the literature review and discussion.
format Online
Article
Text
id pubmed-4436229
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Termedia Publishing House
record_format MEDLINE/PubMed
spelling pubmed-44362292015-05-26 Follow-up of patients with mycosis fungoides after interferon α2b treatment failure Chmielowska, Ewa Studziński, Maciej Giebel, Sebastian Krause, Anna Olejniczak, Monika Grzanka, Aleksandra Postepy Dermatol Alergol Original Paper INTRODUCTION: Treatment of T cell cutaneous lymphoma( CTCL) is a controversial subject and the effectiveness of treatment is still low. AIM: Report of single center experience of management CTCL after progression after first line treatment. MATERIAL AND METHODS: We present 41 patients with CTCL, 29 received interferon α2b in first line, and 12 of them received second line therapy. RESULTS: Overall response rate for second line therapy was 60%. CONCLUSIONS: Results of the follow-up of patients with mycosis fungoides after interferon α2b treatment failure with the literature review and discussion. Termedia Publishing House 2015-03-30 2015-04 /pmc/articles/PMC4436229/ /pubmed/26015774 http://dx.doi.org/10.5114/pdia.2014.40941 Text en Copyright © 2015 Termedia http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License, permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Original Paper
Chmielowska, Ewa
Studziński, Maciej
Giebel, Sebastian
Krause, Anna
Olejniczak, Monika
Grzanka, Aleksandra
Follow-up of patients with mycosis fungoides after interferon α2b treatment failure
title Follow-up of patients with mycosis fungoides after interferon α2b treatment failure
title_full Follow-up of patients with mycosis fungoides after interferon α2b treatment failure
title_fullStr Follow-up of patients with mycosis fungoides after interferon α2b treatment failure
title_full_unstemmed Follow-up of patients with mycosis fungoides after interferon α2b treatment failure
title_short Follow-up of patients with mycosis fungoides after interferon α2b treatment failure
title_sort follow-up of patients with mycosis fungoides after interferon α2b treatment failure
topic Original Paper
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4436229/
https://www.ncbi.nlm.nih.gov/pubmed/26015774
http://dx.doi.org/10.5114/pdia.2014.40941
work_keys_str_mv AT chmielowskaewa followupofpatientswithmycosisfungoidesafterinterferona2btreatmentfailure
AT studzinskimaciej followupofpatientswithmycosisfungoidesafterinterferona2btreatmentfailure
AT giebelsebastian followupofpatientswithmycosisfungoidesafterinterferona2btreatmentfailure
AT krauseanna followupofpatientswithmycosisfungoidesafterinterferona2btreatmentfailure
AT olejniczakmonika followupofpatientswithmycosisfungoidesafterinterferona2btreatmentfailure
AT grzankaaleksandra followupofpatientswithmycosisfungoidesafterinterferona2btreatmentfailure

Ejemplares similares